These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36530982)

  • 1. BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
    Bezrookove V; Khan IA; Nosrati M; Miller JR; McAllister S; Dar AA; Kashani-Sabet M
    Front Oncol; 2022; 12():1011173. PubMed ID: 36530982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
    Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
    J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor.
    Tyutyunyk-Massey L; Sun Y; Dao N; Ngo H; Dammalapati M; Vaidyanathan A; Singh M; Haqqani S; Haueis J; Finnegan R; Deng X; Kirberger SE; Bos PD; Bandyopadhyay D; Pomerantz WCK; Pommier Y; Gewirtz DA; Landry JW
    Mol Cancer Res; 2021 Aug; 19(8):1338-1349. PubMed ID: 33811160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
    Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
    Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
    Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
    Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
    Khan I; Kashani-Sabet M
    Clin Exp Metastasis; 2024 Aug; 41(4):509-515. PubMed ID: 38683257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma.
    Jiang C; Yang Y; He S; Yue Z; Xing T; Chu P; Yang W; Chen H; Zhao X; Yu Y; Zhang X; Su Y; Guo Y; Ma X
    Biol Proced Online; 2023 May; 25(1):11. PubMed ID: 37170211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF.
    Pan L; Tang Z; Pan L; Tang R
    Biochem Cell Biol; 2019 Aug; 97(4):415-422. PubMed ID: 30481052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BPTF activates the MAPK pathway through coexpression with Raf1 to promote proliferation of T-cell lymphoma.
    Bai D; Zhou Y; Shen F; Gao D; Suo W; Zhang H; Li H
    Oncol Lett; 2022 Jul; 24(1):223. PubMed ID: 35720479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
    De Santis F; Romero-Cordoba SL; Castagnoli L; Volpari T; Faraci S; Fucà G; Tagliabue E; De Braud F; Pupa SM; Di Nicola M
    Cell Oncol (Dordr); 2022 Apr; 45(2):257-274. PubMed ID: 35357654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway.
    Liu W; Yang Y; He B; Ma F; Sun F; Guo M; Zhang M; Dong Z
    Ann Transl Med; 2021 Apr; 9(7):533. PubMed ID: 33987231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B; Kucuk O; Moreno CS
    J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A.
    Guo P; Zu S; Han S; Yu W; Xue G; Lu X; Lin H; Zhao X; Lu H; Hua C; Wan X; Ru L; Guo Z; Ge H; Lv K; Zhang G; Deng W; Luo C; Guo W
    Redox Biol; 2022 Sep; 55():102418. PubMed ID: 35932692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.